BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
Atopic dermatitis is a chronic inflammatory disease of the skin with an
onset typically already in infancy. It affects up to 20 per cent
general population in the Western countries, and the prevalence rate is
rising. Atopic dermatitis may significantly impair the quality of life ...
Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
...f Octaplas(R) to satisfy
usual client demand. Production can be increased by up to 30 percent if
demand increases. Octapharma already provides 100 per cent
of plasma needs
with Octaplas(R) for transfusion in Norway, Finland and Portugal.
During the manufacture of Octaplas(R), the product undergoes ...
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
... through Accipiter Capital Management, LLC and associated companies decreased holdings in the Company to 2,814,932 common shares, representing 4.8 per cent
voting rights attached to the issued common share capital of the Company, being 58,216,309 common shares. This information is being provided in order ...
New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
...ease in the risk of cardiovascular death by 29 per cent
(p=0.03) in patients with AF. Multaq significantly decreased the risk of arrhythmic death by 45 per cent
(p=0.01) and there were numerically fewer deaths (...rdiovascular hospitalization was reduced by 26 per cent
(p<0.001) in the dronedarone group.
CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
Across Europe, 5.1 million people are estimated to have psoriasis(2), a
distressing chronic inflammatory disease. Approximately 80 per cent
patients have plaque psoriasis, which is characterised by red, scaly
patches.(3) Psoriasis can be extremely distressing, and may have a
Critical Pharmaceuticals Enter Sustained Release hGH Arena
...oincides with a recent report by Frost & Sullivan valuing the European
market at $846.4m in 2007, with a compound annual growth rate (CAGR) of 2.4
from 2007 to 2014. The report also highlighted new delivery
methods together with approval for new indications as keys to success.
According to Chie...
New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy
...-term open-label therapy, including:5
- 16 per cent
mean relative improvement in overall quality of life (p<0.0001).
- 51 per cent
improvement in worry about seizures (p<0.0001)
- 41 per cent
improvement in social function (p Improvement in ...
Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
...e LAI was 29 cases (in 28
patients) after more than 40,000 injections, yielding a per-injection rate
of 0.07 percent and a per-patient rate of 1.4 per cent
- or approximately
one event per 1,400 injections. No clinically significant decreases in
vital signs were observed and all patients recovered complet...
AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
...ngapore and in the region. It was
established in 1997 and sees about 68 per cent
of the public sector medical
oncology cases and 74 per cent
of radiation oncology cases. NCCS not only
houses the most number of oncolo...
New Australian Technology: Detecting Breast Cancer With Hair
...(hairs treated with dyes or other
chemicals) the accuracy rate of the Test increased to 75%.
The result of Fermiscan's trial also showed that 80 per cent
patients referred for a biopsy as a result of imaging were correctly
identified as negative by the Fermiscan Test. This highlights the Test's
Clinically Proven Treatment Offers Help to Rosacea Sufferers
...reament is a soap with a special ingredient
that kills the parasite - seabuckthorn oil."
"The oil in the soap is clinically proven to destroy 80 per cent
parasite on people with normal skin," Lepage says. "For people with
rosacea, it allows their skin to return to its normal skin tone."
Folate in Strawberries May Contribute to Healthy Pregnancy
strawberries, a natural source of folate.
"The good news for strawberry lovers is that a serving of eight medium
berries provides nearly 9 per cent
of the daily requirement of folate,"
says Chris Christian, vice president trade and nutrition of the California
Strawberry Commission. "Folic acid is ...
Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market
...ointestinal supplements market in the United States is
extremely lucrative with the category worth US$819 million in 2006 and
growing at around 16 per cent
per year. Mr Wilkinson said Vital Foods was
confident their innovative product would be welcomed by American consumers
looking for a natural and prove...
Gastric Banding Reverses Impact of Type 2 Diabetes
...ers for two years who underwent significant weight loss
of more than 10 per cent
of their body weight.
Dr Dixon said of those who underwent gastric bandin...t loss was a key determinant of
effectiveness. Most of those losing ten per cent
of their total weight had
remission of the diabetes. Few who lost less did ...
Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
2004. Notes to Editor: About Non-Small Cell Lung Cancer (NSCLC) NSCLC is the most common type of lung cancer and represents 75 to 80
of all lung cancers.(i) NSCLC has five-tier staging, starting at 0
and rising to the severity of stage IV.(ii) NSCLC can spread through the
Spherix Reports Second Quarter Earnings
...of $699,000, or 5 cents per share, in the second
quarter of 2006. Income from discontinued operations in the second quarter
of 2007 was $155,000, or 1 cent
per share, compared to $938,000, or 7 cents
per share, reflecting the results of the InfoSpherix subsidiary, which the
Company has agreed to sell (see...
First Study To Show Positive Benefit On Atherosclerosis For People
With Early Signs Of Diseased Arteries
CRESTOR brought about a 0.79 per cent
(median) reduction in
percent atheroma volume in t... primary endpoint
CRESTOR brought about a 9.1 per cent
(median) reduction in total
atheroma volume in the... target
CRESTOR brought about a 6.8 per cent
(median) reduction in total
atheroma volume in the...
Mircera Effective in Stabilising Haemoglobin Levels in Elderly
Patients With Kidney Disease on Dialysis
...KD patients on dialysis is projected to grow
7 per cent
per year and it is estimated that by 2010, there w...ysis was 60 years of age
(however more than 40 per cent
of patients were over age 65) and
patients had alr... at the time patients reach ESRD, more
than 50 per cent
of patients have congestive heart failure, heart
Apollo's human proteins boost stem cell research
...ourced from animal,
yeast or bacterial cells.
Mr Priest said that a recent study by Apollo showed that two of
its human proteins were over 50 per cent
more effective than
proteins produced from bacteria in stimulating the growth of
haematopoietic (blood-producing) stem cells.
"Proteins from human c...
Major New Review Supports the Broader Potential of CeNeS COMT
Inhibitor Discovery Programme
... Parkinson's disease Parkinson's disease is the second most
common neurodegenerative disease after Alzheimer's disease. It
affects approximately 2 per cent
of the population over the age of
65, representing approximately 4 million patients worldwide.
Parkinson's disease results from a loss of the neurotra...